X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials

    Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials

    Catalent acquires cell and gene therapy-focused MaSTherCell for $315m

    Cytiva and NecstGen form strategic collaboration to accelerate development of cell and gene therapies

    Astrazeneca Says Covid-19 Long-Acting Antibody Combination AZD7442 Rapidly Advances Into Phase III Clinical Trials

    Valneva and Pfizer Report Further Positive Phase 2 Data for Lyme Disease Vaccine Candidate

    BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology

    BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology

    New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma's VP3 Nasal Spray System

    New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma’s VP3 Nasal Spray System

    Cryoport and Cell Matters Enter into Strategic Partnership

    Cryoport and Cell Matters Enter into Strategic Partnership

    Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

    Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

    Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19

    Gilead Sciences Announces FDA Approval of Veklury for Treatment of Non-Hospitalized Patients at High Risk for COVID-19

    Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations

    Australia Therapeutic Goods Administration Grants Provisional Registration for Novavax COVID-19 Vaccine

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials

    Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials

    Catalent acquires cell and gene therapy-focused MaSTherCell for $315m

    Cytiva and NecstGen form strategic collaboration to accelerate development of cell and gene therapies

    Astrazeneca Says Covid-19 Long-Acting Antibody Combination AZD7442 Rapidly Advances Into Phase III Clinical Trials

    Valneva and Pfizer Report Further Positive Phase 2 Data for Lyme Disease Vaccine Candidate

    BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology

    BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology

    New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma's VP3 Nasal Spray System

    New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma’s VP3 Nasal Spray System

    Cryoport and Cell Matters Enter into Strategic Partnership

    Cryoport and Cell Matters Enter into Strategic Partnership

    Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

    Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

    Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19

    Gilead Sciences Announces FDA Approval of Veklury for Treatment of Non-Hospitalized Patients at High Risk for COVID-19

    Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations

    Australia Therapeutic Goods Administration Grants Provisional Registration for Novavax COVID-19 Vaccine

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Uncategorised

Utilizing QSP Models in Drug Discovery & Development

Yuvraj_pawp by Yuvraj_pawp
12th December 2016
in Uncategorised
If you are having trouble viewing this email click here to see the online version

 

 
   
Hi,
 
Despite advances in traditional PK/PD models utilizing empirical mathematical relationships to link dose, exposure, and response; attrition rates remain appallingly high. Quantitative Systems Pharmacology (QSP) seeks to help you address this methodological gap by mathematically integrating pharmacokinetics, pharmacological response and disease progress/modulation.
 
The 3rd annual QSP 2016 will once again bring together a world-class group of scientists from both academia and industry. Through case study driven presentations, they will detail how QSP models are successfully informing their immuno-oncology, inflammation and metabolic disease drug development pipelines. This is your chance to explore the recent developments in mechanistic and system modeling in toxicology.
 
Download the full event guide for the complete agenda and speaker line-up.
 
Join the conversation with 20+ pioneers including:
  • Bruce Gomes, Executive Director, Novartis
  • CJ Musante, Associate Research Fellow, Pfizer
  • Antje Walz, Senior Principal Scientist Quantitative Systems Pharmacology, Hoffman La Roche
  • Tarek Liel, Group Director, Head of Quantitative Clinical Phamacology, Bristol Myers Squibb
  • Karim Azer, Senior Director Clinical Pharmacology, Sanofi
  • Birgit Schoeberl, Head of Discovery & SVP, Merrimack
  • Sergey Ermakov, Principal Scientist, Clinical Pharmacology, Modeling and Simulation, Amgen

You’ll leave inspired with methods to overcome key challenges in model development including model standardization, population variation, biological uncertainty and integrating omics and large scale data.
 
Download the full event guide for full details, or email me if you have any questions.
 
I hope you can join us at QSP 2016.
 
Kind regards,
Adam
 
Adam Cohen
Program Director
Hanson Wade
 
   
 

Should you no longer wish to receive emails sent to info@worldpharmatoday.com from Hanson Wade about this or other events please {unsubscribe}update your subscription preferences{/unsubscribe}.

View our full Privacy Policy.

© 2016 Hanson Wade Ltd, 52 Grosvenor Gardens, London, SW1W 0AU, United Kingdom.

 

 

Previous Post

Natco Pharma launches Tamiflu generic capsules in US

Next Post

seminar on Navigating thenew regulatory environment for pharmaceutical innovation

Related Posts

Uncategorised

‘Report on key opportunities for advancing clinical trials today’

12th December 2016
Uncategorised

Better data, better engagement, better trials – webinar

12th December 2016
Uncategorised

CPhl Istanbul 2016 : Discover the number one pharmaceutical event in the MENA region

12th December 2016
Uncategorised

seminar on Navigating thenew regulatory environment for pharmaceutical innovation

12th December 2016
Next Post

seminar on Navigating thenew regulatory environment for pharmaceutical innovation

Latest News

Envirotainer introduces the RAP for the future - part of the Releye series
Packaging & Logistic

Envirotainer introduces the RAP for the future – part of the Releye series

14th February 2022
United Cargo Meets Growing Demand for Pharmaceuticals with New TempControl Containers
Packaging & Logistic

Opticooler receives technical approval by Japanese major airlines

14th February 2022
Aptar Pharma Launches HeroTracker Sense, Novel Connected Smart Device for Respiratory Disease
Press Statements

Aptar Pharma Launches HeroTracker Sense, Novel Connected Smart Device for Respiratory Disease

14th February 2022
Johnson & Johnson Prepares to Resume Phase 3 ENSEMBLE Trial of its Janssen COVID-19 Vaccine Candidate in the U.S.
News

Indian Scientists Claim To Design Vaccine For All Variants

9th February 2022
Drones for Delivery To Carry Pharmaceutical Weight Forward
News

Drones for Delivery To Carry Pharmaceutical Weight Forward

9th February 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In